AU2003205622A1 - Aza-arylpiperazines - Google Patents

Aza-arylpiperazines

Info

Publication number
AU2003205622A1
AU2003205622A1 AU2003205622A AU2003205622A AU2003205622A1 AU 2003205622 A1 AU2003205622 A1 AU 2003205622A1 AU 2003205622 A AU2003205622 A AU 2003205622A AU 2003205622 A AU2003205622 A AU 2003205622A AU 2003205622 A1 AU2003205622 A1 AU 2003205622A1
Authority
AU
Australia
Prior art keywords
arylpiperazines
aza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003205622A
Other versions
AU2003205622B2 (en
Inventor
David Reginald Adams
Jonathan Mark Bentley
Toby Jonathan Blench
Paul Hebeisen
Nathaniel Julius Thomas Monck
Hans Richter
Stephan Roever
Jonathan Richard Anthony Roffey
Sven Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Vernalis Research Ltd
Original Assignee
F Hoffmann La Roche AG
Vernalis Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0202015.4A priority Critical patent/GB0202015D0/en
Priority to GB0202015.4 priority
Application filed by F Hoffmann La Roche AG, Vernalis Research Ltd filed Critical F Hoffmann La Roche AG
Priority to PCT/EP2003/000459 priority patent/WO2003064423A1/en
Publication of AU2003205622A1 publication Critical patent/AU2003205622A1/en
Application granted granted Critical
Publication of AU2003205622B2 publication Critical patent/AU2003205622B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2003205622A 2002-01-29 2003-01-17 Aza-arylpiperazines Ceased AU2003205622B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0202015.4A GB0202015D0 (en) 2002-01-29 2002-01-29 Piperazine Derivatives
GB0202015.4 2002-01-29
PCT/EP2003/000459 WO2003064423A1 (en) 2002-01-29 2003-01-17 Aza-arylpiperazines

Publications (2)

Publication Number Publication Date
AU2003205622A1 true AU2003205622A1 (en) 2003-09-18
AU2003205622B2 AU2003205622B2 (en) 2006-10-19

Family

ID=9929954

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003205622A Ceased AU2003205622B2 (en) 2002-01-29 2003-01-17 Aza-arylpiperazines

Country Status (33)

Country Link
US (1) US7098337B2 (en)
EP (1) EP1472255B1 (en)
JP (1) JP4213042B2 (en)
KR (1) KR100644004B1 (en)
CN (1) CN1290847C (en)
AR (1) AR038237A1 (en)
AT (1) AT318817T (en)
AU (1) AU2003205622B2 (en)
BR (1) BR0307291A (en)
CA (1) CA2472954C (en)
DE (1) DE60303791T2 (en)
DK (1) DK1472255T3 (en)
EA (1) EA200400881A1 (en)
EC (1) ECSP045208A (en)
ES (1) ES2259757T3 (en)
GB (1) GB0202015D0 (en)
GT (1) GT200300015A (en)
HR (1) HRP20040653A2 (en)
IL (1) IL162727D0 (en)
MA (1) MA27097A1 (en)
MX (1) MXPA04007147A (en)
NO (1) NO20043547L (en)
PA (1) PA8564001A1 (en)
PE (1) PE20030847A1 (en)
PL (1) PL371922A1 (en)
PT (1) PT1472255E (en)
RS (1) RS65704A (en)
SI (1) SI1472255T1 (en)
TN (1) TNSN04136A1 (en)
TW (1) TW200307683A (en)
UY (1) UY27627A1 (en)
WO (1) WO2003064423A1 (en)
ZA (1) ZA200405458B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060069792A (en) * 2003-05-21 2006-06-22 프로시디온 리미티드 Pyrrololpyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
GB0314967D0 (en) * 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
AR046132A1 (en) * 2003-10-24 2005-11-23 Solvay Pharm Gmbh Composition pharmaceutical containing the least one compound with activity of CB1 receptor, or a prodrug, tautomer or salt of the same, as active component I suitable for the treatment and / or prophylaxis of diseases related to the CB1 receptor in juvenile patients and / or the treatment
CN1867332A (en) * 2003-10-24 2006-11-22 索尔瓦药物有限公司 Combination treatment of obesity involving selective cb1-antagonists and lipase inhibitors
WO2006022420A1 (en) 2004-08-25 2006-03-02 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
MX2007004889A (en) 2004-10-25 2007-09-11 Solvay Pharm Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions.
KR100895758B1 (en) 2005-05-03 2009-04-30 베르날리스 리서치 리미티드 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
WO2006125179A1 (en) * 2005-05-19 2006-11-23 Xenon Pharmaceuticals Inc. Tricyclic compounds and their uses as therapeutic agents
AU2006314649A1 (en) * 2005-11-18 2007-05-24 F. Hoffmann-La Roche Ag Azaindole-2-carboxamide derivatives
WO2007065820A1 (en) * 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Tricyclic amide derivatives useful for treating obesity
AU2006326067A1 (en) 2005-12-16 2007-06-21 F. Hoffmann-La Roche Ag Pyrrolo [2 , 3-b] pyridine derivatives as H3 receptor modulators
WO2007132841A1 (en) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
AU2007283113A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
EP2789338A3 (en) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Condensed pyridine derivate and use thereof
EP2310372B1 (en) 2008-07-09 2012-05-23 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
PT2470552E (en) 2009-08-26 2014-01-30 Sanofi Sa Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
JPWO2011071136A1 (en) 2009-12-11 2013-04-22 アステラス製薬株式会社 Fibromyalgia treatment
FR2960876B1 (en) * 2010-06-03 2012-07-27 Sanofi Aventis 3,4-dihydropyrrolo [1,2-a] pyrazine-2,8 (1h) -dicarboxamide derivatives for their preparation and their therapeutic use.
EP2683698B1 (en) 2011-03-08 2017-10-04 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683704B1 (en) 2011-03-08 2014-12-17 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683700B1 (en) 2011-03-08 2015-02-18 Sanofi Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use
EP2766349B1 (en) 2011-03-08 2016-06-01 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120057A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8846666B2 (en) 2011-03-08 2014-09-30 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683705B1 (en) 2011-03-08 2015-04-22 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
KR101716062B1 (en) * 2012-08-06 2017-03-13 에프. 호프만-라 로슈 아게 Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-27 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5274143A (en) 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
TR200100472T2 (en) 1998-08-14 2001-07-23 F.Hoffmann-La Roche Ag Pharmaceutical compositions containing chitosan with lipase inhibitors
DE69924999T2 (en) 1998-08-14 2006-05-04 F. Hoffmann-La Roche Ag Lipasehemmer containing pharmaceutical compositions
GB9902047D0 (en) * 1999-01-29 1999-03-17 Cerebrus Ltd Chemical compounds XI
FR2799757B1 (en) * 1999-10-15 2001-12-14 Adir Novel azaindolic polycyclic derivatives, their preparation process and the pharmaceutical compositions containing them

Similar Documents

Publication Publication Date Title
AU2003283323A1 (en) Toothbrush
AU2003210222A1 (en) Toothbrush
AU2003243226A1 (en) Vitamin-mitomycin conjugates
AU2003276458A1 (en) 2-oxo-ethanesulfonamide derivates
AU2003287181A1 (en) Spectrum-adaptive networking
WO2003106635A9 (en) Functional sites
AU2003289047A1 (en) Needle-insertion device
AU2003237647A1 (en) Lid-positioning device
AU2003281272A1 (en) Fireblocking device
AU2003225031A1 (en) Eptfe-reinforced perfluoroelastomers
AU2003275612A1 (en) Defructosylation method
AU2003279369A1 (en) Device
AU2003265509A1 (en) Neurostimulator
AU2003262722A1 (en) Subwoofer
AU2002352768A1 (en) Multifunctional world-wide-walkie-talkie
AU2002359884A1 (en) An improved control - hold mode
AU2003270592A1 (en) Anti-entrapment system
AU2003231825A1 (en) Fluoro-silane-oligomer composition
AU2002951728A0 (en) Component interlocking
AU2003216002A1 (en) Efficient mmicrofluidic devices
AU2003279366A1 (en) Novel compounds
AU2003244672A1 (en) Positioning technique
AU2003245720A1 (en) Electroptic device
AU2003252586A1 (en) Individual cryptoprotective complex
AU2003299588A1 (en) Pipe-inspection system